Treatment of dyskinesia with a h3-histamine receptor agonist

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4164 (2006.01) A61K 31/00 (2006.01) A61K 31/155 (2006.01) A61K 31/198 (2006.01) A61K 31/417 (2006.01) A61K 31/454 (2006.01) A61K 31/473 (2006.01) A61K 31/55 (2006.01) A61K 48/00 (2006.01) A61P 25/14 (2006.01) A61P 25/16 (2006.01)

Patent

CA 2389476

The present invention relates to the use of compounds that enhance H3-histamine receptor activity, or activation (e.g. H3-histamine receptor agonists) for the treatment of dyskinesia. The compounds are particularly useful for treating dyskinesia associated with parkinsonian therapy.

La présente invention concerne l'utilisation de composés qui augmentent l'activité du récepteur H3 de l'histamine ou l'activation de ce dernier (par exemple, par les agonistes du récepteur H3 de l'histamine) dans le traitement de la dyskinésie. Les composés de l'invention sont particulièrement utiles dans le traitement de la dyskinésie associé à la thérapie de la maladie de Parkinson.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of dyskinesia with a h3-histamine receptor agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of dyskinesia with a h3-histamine receptor agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of dyskinesia with a h3-histamine receptor agonist will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2042917

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.